Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease

Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet M-F, et al. (2016)
Cell 167(6): 1469-1480.e12.

Zeitschriftenaufsatz | Veröffentlicht| Englisch
 
Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Autor*in
Sampson, Timothy R; Debelius, Justine W; Thron, Taren; Janssen, StefanUniBi ; Shastri, Gauri G; Ilhan, Zehra Esra; Challis, Collin; Schretter, Catherine E; Rocha, Sandra; Gradinaru, Viviana; Chesselet, Marie-Francoise; Keshavarzian, Ali
Alle
Erscheinungsjahr
2016
Zeitschriftentitel
Cell
Band
167
Ausgabe
6
Seite(n)
1469-1480.e12
ISBN
0092-8674
Page URI
https://pub.uni-bielefeld.de/record/2907305

Zitieren

Sampson TR, Debelius JW, Thron T, et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell. 2016;167(6):1469-1480.e12.
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., et al. (2016). Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell, 167(6), 1469-1480.e12. doi:10.1016/j.cell.2016.11.018
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016). Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell 167, 1469-1480.e12.
Sampson, T.R., et al., 2016. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell, 167(6), p 1469-1480.e12.
T.R. Sampson, et al., “Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease”, Cell, vol. 167, 2016, pp. 1469-1480.e12.
Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., Challis, C., Schretter, C.E., Rocha, S., Gradinaru, V., Chesselet, M.-F., Keshavarzian, A., Shannon, K.M., Krajmalnik-Brown, R., Wittung-Stafshede, P., Knight, R., Mazmanian, S.K.: Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell. 167, 1469-1480.e12 (2016).
Sampson, Timothy R, Debelius, Justine W, Thron, Taren, Janssen, Stefan, Shastri, Gauri G, Ilhan, Zehra Esra, Challis, Collin, Schretter, Catherine E, Rocha, Sandra, Gradinaru, Viviana, Chesselet, Marie-Francoise, Keshavarzian, Ali, Shannon, Kathleen M, Krajmalnik-Brown, Rosa, Wittung-Stafshede, Pernilla, Knight, Rob, and Mazmanian, Sarkis K. “Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease”. Cell 167.6 (2016): 1469-1480.e12.

309 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

A neuroscience perspective of the gut theory of Parkinson's disease.
Smith LM, Parr-Brownlie LC., Eur J Neurosci 49(6), 2019
PMID: 29446158
Photobiomodulation of the microbiome: implications for metabolic and inflammatory diseases.
Bicknell B, Liebert A, Johnstone D, Kiat H., Lasers Med Sci 34(2), 2019
PMID: 30074108
The mammalian mycobiome: A complex system in a dynamic relationship with the host.
Lai GC, Tan TG, Pavelka N., Wiley Interdiscip Rev Syst Biol Med 11(1), 2019
PMID: 30255552
Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease.
Maraki MI, Yannakoulia M, Stamelou M, Stefanis L, Xiromerisiou G, Kosmidis MH, Dardiotis E, Hadjigeorgiou GM, Sakka P, Anastasiou CA, Simopoulou E, Scarmeas N., Mov Disord 34(1), 2019
PMID: 30306634
The Effects of Probiotic Formulation Pretreatment (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) on a Lipopolysaccharide Rat Model.
Mohammadi G, Dargahi L, Peymani A, Mirzanejad Y, Alizadeh SA, Naserpour T, Nassiri-Asl M., J Am Coll Nutr 38(3), 2019
PMID: 30307792
Enlisting commensal microbes to resist antibiotic-resistant pathogens.
Keith JW, Pamer EG., J Exp Med 216(1), 2019
PMID: 30309968
Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis.
Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P., Trends Neurosci 42(1), 2019
PMID: 30342839
Microbiome-microglia connections via the gut-brain axis.
Abdel-Haq R, Schlachetzki JCM, Glass CK, Mazmanian SK., J Exp Med 216(1), 2019
PMID: 30385457
Making Sense of … the Microbiome in Psychiatry.
Bastiaanssen TFS, Cowan CSM, Claesson MJ, Dinan TG, Cryan JF., Int J Neuropsychopharmacol 22(1), 2019
PMID: 30099552
Brain-Gut-Microbiota Axis in Alzheimer's Disease.
Kowalski K, Mulak A., J Neurogastroenterol Motil 25(1), 2019
PMID: 30646475
The gut microbiome of healthy long-living people.
Deng F, Li Y, Zhao J., Aging (Albany NY) 11(2), 2019
PMID: 30648974
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice.
Britton GJ, Contijoch EJ, Mogno I, Vennaro OH, Llewellyn SR, Ng R, Li Z, Mortha A, Merad M, Das A, Gevers D, McGovern DPB, Singh N, Braun J, Jacobs JP, Clemente JC, Grinspan A, Sands BE, Colombel JF, Dubinsky MC, Faith JJ., Immunity 50(1), 2019
PMID: 30650377
The Dimension of Time in Host-Microbiome Interactions.
Uhr GT, Dohnalová L, Thaiss CA., mSystems 4(1), 2019
PMID: 30801030
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease.
van Kessel SP, Frye AK, El-Gendy AO, Castejon M, Keshavarzian A, van Dijk G, El Aidy S., Nat Commun 10(1), 2019
PMID: 30659181
Gut microbiota density influences host physiology and is shaped by host and microbial factors.
Contijoch EJ, Britton GJ, Yang C, Mogno I, Li Z, Ng R, Llewellyn SR, Hira S, Johnson C, Rabinowitz KM, Barkan R, Dotan I, Hirten RP, Fu SC, Luo Y, Yang N, Luong T, Labrias PR, Lira S, Peter I, Grinspan A, Clemente JC, Kosoy R, Kim-Schulze S, Qin X, Castillo A, Hurley A, Atreja A, Rogers J, Fasihuddin F, Saliaj M, Nolan A, Reyes-Mercedes P, Rodriguez C, Aly S, Santa-Cruz K, Peters L, Suárez-Fariñas M, Huang R, Hao K, Zhu J, Zhang B, Losic B, Irizar H, Song WM, Di Narzo A, Wang W, Cohen BL, DiMaio C, Greenwald D, Itzkowitz S, Lucas A, Marion J, Maser E, Ungaro R, Naymagon S, Novak J, Shah B, Ullman T, Rubin P, George J, Legnani P, Telesco SE, Friedman JR, Brodmerkel C, Plevy S, Cho JH, Colombel JF, Schadt EE, Argmann C, Dubinsky M, Kasarskis A, Sands B, Faith JJ., Elife 8(), 2019
PMID: 30666957
Fecal microbiota changes associated with dehorning and castration stress primarily affects light-weight dairy calves.
Mir RA, Kleinhenz MD, Coetzee JF, Allen HK, Kudva IT., PLoS One 14(1), 2019
PMID: 30673718
Fto Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice via Alterations in Gut Microbiota.
Sun L, Ma L, Zhang H, Cao Y, Wang C, Hou N, Huang N, von Deneen KM, Zhao C, Shi Y, Pan Y, Wang M, Ji G, Nie Y., Theranostics 9(3), 2019
PMID: 30809304
Oral neonatal antibiotic treatment perturbs gut microbiota and aggravates central nervous system autoimmunity in Dark Agouti rats.
Stanisavljević S, Čepić A, Bojić S, Veljović K, Mihajlović S, Đedović N, Jevtić B, Momčilović M, Lazarević M, Mostarica Stojković M, Miljković Đ, Golić N., Sci Rep 9(1), 2019
PMID: 30696913
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.
Zella MAS, Metzdorf J, Ostendorf F, Maass F, Muhlack S, Gold R, Haghikia A, Tönges L., Cells 8(2), 2019
PMID: 30708997
[The gut microbiome in Parkinson's disease].
Bedarf JR, Hildebrand F, Goeser F, Bork P, Wüllner U., Nervenarzt 90(2), 2019
PMID: 30171304
The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice.
Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, Liu Y, Cheng K, Zhou C, Wang H, Zhou X, Gui S, Perry SW, Wong ML, Licinio J, Wei H, Xie P., Sci Adv 5(2), 2019
PMID: 30775438
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuña J, Elgueta D, Pacheco R., Front Immunol 10(), 2019
PMID: 30828335
Glabridin Prevents Doxorubicin-Induced Cardiotoxicity Through Gut Microbiota Modulation and Colonic Macrophage Polarization in Mice.
Huang K, Liu Y, Tang H, Qiu M, Li C, Duan C, Wang C, Yang J, Zhou X., Front Pharmacol 10(), 2019
PMID: 30833897
Metabolomics-based identification of metabolic alterations in PARK2.
Okuzumi A, Hatano T, Ueno SI, Ogawa T, Saiki S, Mori A, Koinuma T, Oji Y, Ishikawa KI, Fujimaki M, Sato S, Ramamoorthy S, Mohney RP, Hattori N., Ann Clin Transl Neurol 6(3), 2019
PMID: 30911576
Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
Garretti F, Agalliu D, Lindestam Arlehamn CS, Sette A, Sulzer D., Front Immunol 10(), 2019
PMID: 30858851
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis.
Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang RF., J Neuroinflammation 16(1), 2019
PMID: 30823925
Probiotic Bifidobacterium lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients through the Gut-Brain Axis.
Zhang J, Sun Z, Jiang S, Bai X, Ma C, Peng Q, Chen K, Chang H, Fang T, Zhang H., mSystems 4(2), 2019
PMID: 31020040
Microbiome, Parkinson's Disease and Molecular Mimicry.
Miraglia F, Colla E., Cells 8(3), 2019
PMID: 30866550
DL-3-n-butylphthalide therapy for Parkinson's disease: A randomized controlled trial.
Zhou H, Ye M, Xu W, Yu M, Liu X, Chen Y., Exp Ther Med 17(5), 2019
PMID: 30988766
Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis.
Kadowaki A, Saga R, Lin Y, Sato W, Yamamura T., Brain 142(4), 2019
PMID: 30770703
LRRK2 in Infection: Friend or Foe?
Herbst S, Gutierrez MG., ACS Infect Dis 5(6), 2019
PMID: 30915830
APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology.
Tran TTT, Corsini S, Kellingray L, Hegarty C, Le Gall G, Narbad A, Müller M, Tejera N, O'Toole PW, Minihane AM, Vauzour D., FASEB J 33(7), 2019
PMID: 30958695
Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson's Disease.
Bajracharya R, Youngson NA, Ballard JWO., Int J Mol Sci 20(8), 2019
PMID: 30991634
Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson's Disease.
Fitzgerald E, Murphy S, Martinson HA., Front Neurosci 13(), 2019
PMID: 31068777
Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved.
Vasili E, Dominguez-Meijide A, Outeiro TF., Front Mol Neurosci 12(), 2019
PMID: 31105524
Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse Model.
Elgueta D, Contreras F, Prado C, Montoya A, Ugalde V, Chovar O, Villagra R, Henríquez C, Abellanas MA, Aymerich MS, Franco R, Pacheco R., Front Immunol 10(), 2019
PMID: 31118938
Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence.
Magistrelli L, Amoruso A, Mogna L, Graziano T, Cantello R, Pane M, Comi C., Front Immunol 10(), 2019
PMID: 31134068
Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China.
Zhou X, Guo J, Sun Q, Xu Q, Pan H, Yu R, Tan J, Yan X, Tang B, Fang L., Front Neurol 10(), 2019
PMID: 31164859
Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease.
Chiang HL, Lin CH., J Mov Disord 12(2), 2019
PMID: 31158941
Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report.
Huang H, Xu H, Luo Q, He J, Li M, Chen H, Tang W, Nie Y, Zhou Y., Medicine (Baltimore) 98(26), 2019
PMID: 31261545
The Gut and Parkinson's Disease-A Bidirectional Pathway.
Santos SF, de Oliveira HL, Yamada ES, Neves BC, Pereira A., Front Neurol 10(), 2019
PMID: 31214110
Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions.
Gómez-Gómez ME, Zapico SC., Int J Mol Sci 20(11), 2019
PMID: 31212645
The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review.
Ambrosini YM, Borcherding D, Kanthasamy A, Kim HJ, Willette AA, Jergens A, Allenspach K, Mochel JP., Front Aging Neurosci 11(), 2019
PMID: 31275138
Association of Parkinson's disease and treatment with aminosalicylates in inflammatory bowel disease: a cross-sectional study in a Spain drug dispensation records.
Pinel Ríos J, Madrid Navarro CJ, Pérez Navarro MJ, Cabello Tapia MJ, Piña Vera MJ, Campos Arillo V, Gómez García MR, Mínguez Castellanos A, Escamilla Sevilla F., BMJ Open 9(6), 2019
PMID: 31221869
Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications.
Limphaibool N, Iwanowski P, Holstad MJV, Kobylarek D, Kozubski W., Front Neurol 10(), 2019
PMID: 31275235
Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease.
Cantu-Jungles TM, Rasmussen HE, Hamaker BR., Front Neurol 10(), 2019
PMID: 31281287
Distal Consequences of Oral Inflammation.
Konkel JE, O'Boyle C, Krishnan S., Front Immunol 10(), 2019
PMID: 31293577
Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP, Chuang EY, Tai YC, Cheng C, Lin HY, Wu MS., J Neuroinflammation 16(1), 2019
PMID: 31248424
Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids.
Li JM, Yu R, Zhang LP, Wen SY, Wang SJ, Zhang XY, Xu Q, Kong LD., Microbiome 7(1), 2019
PMID: 31255176
Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation.
Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, Nair PP., J Neurogastroenterol Motil 25(3), 2019
PMID: 31327219
Single-Cell Glia and Neuron Gene Expression in the Central Amygdala in Opioid Withdrawal Suggests Inflammation With Correlated Gut Dysbiosis.
O'Sullivan SJ, Malahias E, Park J, Srivastava A, Reyes BAS, Gorky J, Vadigepalli R, Van Bockstaele EJ, Schwaber JS., Front Neurosci 13(), 2019
PMID: 31333398
Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China.
Li C, Cui L, Yang Y, Miao J, Zhao X, Zhang J, Cui G, Zhang Y., Front Mol Neurosci 12(), 2019
PMID: 31354427
The microbiota protects from viral-induced neurologic damage through microglia-intrinsic TLR signaling.
Brown DG, Soto R, Yandamuri S, Stone C, Dickey L, Gomes-Neto JC, Pastuzyn ED, Bell R, Petersen C, Buhrke K, Fujinami RS, O'Connell RM, Stephens WZ, Shepherd JD, Lane TE, Round JL., Elife 8(), 2019
PMID: 31309928
Gut Microbiome: Profound Implications for Diet and Disease.
Hills RD, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR., Nutrients 11(7), 2019
PMID: 31315227
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson's disease.
Hallett PJ, Engelender S, Isacson O., J Neuroinflammation 16(1), 2019
PMID: 31331333
Massive metagenomic data analysis using abundance-based machine learning.
Harris ZN, Dhungel E, Mosior M, Ahn TH., Biol Direct 14(1), 2019
PMID: 31370905
Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model.
Gorecki AM, Preskey L, Bakeberg MC, Kenna JE, Gildenhuys C, MacDougall G, Dunlop SA, Mastaglia FL, Akkari PA, Koengten F, Anderton RS., Front Neurosci 13(), 2019
PMID: 31440136
The microbiome regulates amygdala-dependent fear recall.
Hoban AE, Stilling RM, Moloney G, Shanahan F, Dinan TG, Clarke G, Cryan JF., Mol Psychiatry 23(5), 2018
PMID: 28507320
Recent developments in understanding the role of the gut microbiota in brain health and disease.
Sherwin E, Dinan TG, Cryan JF., Ann N Y Acad Sci 1420(1), 2018
PMID: 28768369
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
Heintz-Buschart A, Pandey U, Wicke T, Sixel-Döring F, Janzen A, Sittig-Wiegand E, Trenkwalder C, Oertel WH, Mollenhauer B, Wilmes P., Mov Disord 33(1), 2018
PMID: 28843021
Harnessing Gut Microbes for Mental Health: Getting From Here to There.
Bruce-Keller AJ, Salbaum JM, Berthoud HR., Biol Psychiatry 83(3), 2018
PMID: 29031410
Impacts of the Human Gut Microbiome on Therapeutics.
Vázquez-Baeza Y, Callewaert C, Debelius J, Hyde E, Marotz C, Morton JT, Swafford A, Vrbanac A, Dorrestein PC, Knight R., Annu Rev Pharmacol Toxicol 58(), 2018
PMID: 28968189
Nutritional habits, risk, and progression of Parkinson disease.
Erro R, Brigo F, Tamburin S, Zamboni M, Antonini A, Tinazzi M., J Neurol 265(1), 2018
PMID: 29018983
Does Parkinson's disease start in the gut?
Lionnet A, Leclair-Visonneau L, Neunlist M, Murayama S, Takao M, Adler CH, Derkinderen P, Beach TG., Acta Neuropathol 135(1), 2018
PMID: 29039141
Altered gut microbiome and metabolome in patients with multiple system atrophy.
Tan AH, Chong CW, Song SL, Teh CSJ, Yap IKS, Loke MF, Tan YQ, Yong HS, Mahadeva S, Lang AE, Lim SY., Mov Disord 33(1), 2018
PMID: 29083071
In vivo models of alpha-synuclein transmission and propagation.
Recasens A, Ulusoy A, Kahle PJ, Di Monte DA, Dehay B., Cell Tissue Res 373(1), 2018
PMID: 29185072
Tonsillectomy and risk of Parkinson's disease: A danish nationwide population-based cohort study.
Svensson E, Henderson VW, Szépligeti S, Stokholm MG, Klug TE, Sørensen HT, Borghammer P., Mov Disord 33(2), 2018
PMID: 29193401
The Impact of Long-Term Intake of Phenolic Compounds-Rich Grape Pomace on Rat Gut Microbiota.
Chacar S, Itani T, Hajal J, Saliba Y, Louka N, Faivre JF, Maroun R, Fares N., J Food Sci 83(1), 2018
PMID: 29227528
Microbiome Influences Prenatal and Adult Microglia in a Sex-Specific Manner.
Thion MS, Low D, Silvin A, Chen J, Grisel P, Schulte-Schrepping J, Blecher R, Ulas T, Squarzoni P, Hoeffel G, Coulpier F, Siopi E, David FS, Scholz C, Shihui F, Lum J, Amoyo AA, Larbi A, Poidinger M, Buttgereit A, Lledo PM, Greter M, Chan JKY, Amit I, Beyer M, Schultze JL, Schlitzer A, Pettersson S, Ginhoux F, Garel S., Cell 172(3), 2018
PMID: 29275859
EBI Metagenomics in 2017: enriching the analysis of microbial communities, from sequence reads to assemblies.
Mitchell AL, Scheremetjew M, Denise H, Potter S, Tarkowska A, Qureshi M, Salazar GA, Pesseat S, Boland MA, Hunter FMI, Ten Hoopen P, Alako B, Amid C, Wilkinson DJ, Curtis TP, Cochrane G, Finn RD., Nucleic Acids Res 46(d1), 2018
PMID: 29069476
An introduction to the microbiome and MS.
Trott S, King IL., Mult Scler 24(1), 2018
PMID: 29307298
Microbiome, Immunomodulation, and the Neuronal System.
Marietta E, Horwath I, Taneja V., Neurotherapeutics 15(1), 2018
PMID: 29313275
Microbiota Signaling Pathways that Influence Neurologic Disease.
Cox LM, Weiner HL., Neurotherapeutics 15(1), 2018
PMID: 29340928
Prion-like propagation of pathology in Parkinson disease.
Volpicelli-Daley L, Brundin P., Handb Clin Neurol 153(), 2018
PMID: 29887143
The Gut and Parkinson's Disease: Hype or Hope?
Scheperjans F, Derkinderen P, Borghammer P., J Parkinsons Dis 8(s1), 2018
PMID: 30584161
Therapies to Slow, Stop, or Reverse Parkinson's Disease.
Foltynie T, Langston JW., J Parkinsons Dis 8(s1), 2018
PMID: 30584162
Gut microbiota in cardiovascular disease and heart failure.
Kitai T, Tang WHW., Clin Sci (Lond) 132(1), 2018
PMID: 29326279
Interactions between species introduce spurious associations in microbiome studies.
Menon R, Ramanan V, Korolev KS., PLoS Comput Biol 14(1), 2018
PMID: 29338008
Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.
Manfredsson FP, Luk KC, Benskey MJ, Gezer A, Garcia J, Kuhn NC, Sandoval IM, Patterson JR, O'Mara A, Yonkers R, Kordower JH., Neurobiol Dis 112(), 2018
PMID: 29341898
Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice.
Choi JG, Kim N, Ju IG, Eo H, Lim SM, Jang SE, Kim DH, Oh MS., Sci Rep 8(1), 2018
PMID: 29352191
Novel models for Parkinson's disease and their impact on future drug discovery.
Trigo-Damas I, Del Rey NL, Blesa J., Expert Opin Drug Discov 13(3), 2018
PMID: 29363335
Targeting Cellular Stress Mechanisms and Metabolic Homeostasis by Chinese Herbal Drugs for Neuroprotection.
Ting HC, Chang CY, Lu KY, Chuang HM, Tsai SF, Huang MH, Liu CA, Lin SZ, Harn HJ., Molecules 23(2), 2018
PMID: 29382106
Parkinson's disease from the gut.
Liddle RA., Brain Res 1693(pt b), 2018
PMID: 29360467
Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder.
Nguyen TT, Kosciolek T, Eyler LT, Knight R, Jeste DV., J Psychiatr Res 99(), 2018
PMID: 29407287
Effect of a neural relay on liver regeneration in mice: activation of serotonin release from the gastrointestinal tract.
Inoue R, Kamimura K, Nagoya T, Sakai N, Yokoo T, Goto R, Ogawa K, Shinagawa-Kobayashi Y, Watanabe-Mori Y, Sakamaki A, Abe S, Kamimura H, Miyamura N, Nishina H, Terai S., FEBS Open Bio 8(3), 2018
PMID: 29511622
Immunologic treatment of Parkinson's disease.
Jankovic J., Immunotherapy 10(2), 2018
PMID: 29260621
Does Parkinson's disease start in the gut?
Gershanik OS., Arq Neuropsiquiatr 76(2), 2018
PMID: 29489958
Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models.
Garrido-Gil P, Rodriguez-Perez AI, Dominguez-Meijide A, Guerra MJ, Labandeira-Garcia JL., Mol Neurobiol 55(9), 2018
PMID: 29404956
How the microbiome challenges our concept of self.
Rees T, Bosch T, Douglas AE., PLoS Biol 16(2), 2018
PMID: 29425197
2017 Year in Review and Message from the Editors to Our Reviewers.
Pulst SM, Johnson NE, Pandolfo M, Roos RP, Vance JM., Neurol Genet 4(1), 2018
PMID: 29552636
Gut Microbiota: An Integral Moderator in Health and Disease.
Feng Q, Chen WD, Wang YD., Front Microbiol 9(), 2018
PMID: 29515527
Of Microbes and Minds: A Narrative Review on the Second Brain Aging.
Calvani R, Picca A, Lo Monaco MR, Landi F, Bernabei R, Marzetti E., Front Med (Lausanne) 5(), 2018
PMID: 29552561
Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson's Disease Penetrance.
Zanon A, Pramstaller PP, Hicks AA, Pichler I., Parkinsons Dis 2018(), 2018
PMID: 29707191
Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection.
Thaiss CA, Levy M, Grosheva I, Zheng D, Soffer E, Blacher E, Braverman S, Tengeler AC, Barak O, Elazar M, Ben-Zeev R, Lehavi-Regev D, Katz MN, Pevsner-Fischer M, Gertler A, Halpern Z, Harmelin A, Aamar S, Serradas P, Grosfeld A, Shapiro H, Geiger B, Elinav E., Science 359(6382), 2018
PMID: 29519916
Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?
Newberry F, Hsieh SY, Wileman T, Carding SR., Clin Sci (Lond) 132(5), 2018
PMID: 29523751
Virus-like particles and enterovirus antigen found in the brainstem neurons of Parkinson's disease.
Dourmashkin RR, McCall SA, Dourmashkin N, Hannah MJ., F1000Res 7(), 2018
PMID: 29899977
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates.
Franceschi C, Garagnani P, Morsiani C, Conte M, Santoro A, Grignolio A, Monti D, Capri M, Salvioli S., Front Med (Lausanne) 5(), 2018
PMID: 29662881
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies.
Edington CD, Chen WLK, Geishecker E, Kassis T, Soenksen LR, Bhushan BM, Freake D, Kirschner J, Maass C, Tsamandouras N, Valdez J, Cook CD, Parent T, Snyder S, Yu J, Suter E, Shockley M, Velazquez J, Velazquez JJ, Stockdale L, Papps JP, Lee I, Vann N, Gamboa M, LaBarge ME, Zhong Z, Wang X, Boyer LA, Lauffenburger DA, Carrier RL, Communal C, Tannenbaum SR, Stokes CL, Hughes DJ, Rohatgi G, Trumper DL, Cirit M, Griffith LG., Sci Rep 8(1), 2018
PMID: 29540740
Dynamic metabolic patterns tracking neurodegeneration and gliosis following 26S proteasome dysfunction in mouse forebrain neurons.
Geiszler PC, Ugun-Klusek A, Lawler K, Pardon MC, Yuchun D, Bai L, Daykin CA, Auer DP, Bedford L., Sci Rep 8(1), 2018
PMID: 29555943
Early signs of colonic inflammation, intestinal dysfunction, and olfactory impairments in the rotenone-induced mouse model of Parkinson's disease.
Morais LH, Hara DB, Bicca MA, Poli A, Takahashi RN., Behav Pharmacol 29(2 and 3-spec issue), 2018
PMID: 29543651
Autonomic nervous system network and liver regeneration.
Kamimura K, Inoue R, Nagoya T, Sakai N, Goto R, Ko M, Niwa Y, Terai S., World J Gastroenterol 24(15), 2018
PMID: 29686468
Abundant fish protein inhibits α-synuclein amyloid formation.
Werner T, Kumar R, Horvath I, Scheers N, Wittung-Stafshede P., Sci Rep 8(1), 2018
PMID: 29615738
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines.
Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA., Front Immunol 9(), 2018
PMID: 29686666
The Brain-Gut-Microbiome Axis.
Martin CR, Osadchiy V, Kalani A, Mayer EA., Cell Mol Gastroenterol Hepatol 6(2), 2018
PMID: 30023410
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.
Zeng XS, Geng WS, Jia JJ, Chen L, Zhang PP., Front Aging Neurosci 10(), 2018
PMID: 29719505
Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.
Lombardi VC, De Meirleir KL, Subramanian K, Nourani SM, Dagda RK, Delaney SL, Palotás A., J Nutr Biochem 61(), 2018
PMID: 29886183
Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model.
Hryckowian AJ, Van Treuren W, Smits SA, Davis NM, Gardner JO, Bouley DM, Sonnenburg JL., Nat Microbiol 3(6), 2018
PMID: 29686297
Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis.
Huang Z, Liu Q, Peng Y, Dai J, Xie Y, Chen W, Long S, Pei Z, Su H, Yao X., Front Neurol 9(), 2018
PMID: 29740382
ELISA method to detect α-synuclein oligomers in cell and animal models.
Lassen LB, Gregersen E, Isager AK, Betzer C, Kofoed RH, Jensen PH., PLoS One 13(4), 2018
PMID: 29698510
Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease.
Bao LH, Zhang YN, Zhang JN, Gu L, Yang HM, Huang YY, Xia N, Zhang H., J Neuroinflammation 15(1), 2018
PMID: 29720230
Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration.
Ghiglieri V, Calabrese V, Calabresi P., Front Neurol 9(), 2018
PMID: 29780350
The Microbiome-Mitochondria Dance in Prodromal Parkinson's Disease.
Cardoso SM, Empadinhas N., Front Physiol 9(), 2018
PMID: 29867531
PLGA Microspheres Loaded with β-Cyclodextrin Complexes of Epigallocatechin-3-Gallate for the Anti-Inflammatory Properties in Activated Microglial Cells.
Cheng CY, Pho QH, Wu XY, Chin TY, Chen CM, Fang PH, Lin YC, Hsieh MF., Polymers (Basel) 10(5), 2018
PMID: 30966553
Postnatal colonization with human "infant-type" Bifidobacterium species alters behavior of adult gnotobiotic mice.
Luk B, Veeraragavan S, Engevik M, Balderas M, Major A, Runge J, Luna RA, Versalovic J., PLoS One 13(5), 2018
PMID: 29763437
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?
Pellegrini C, Antonioli L, Colucci R, Blandizzi C, Fornai M., Acta Neuropathol 136(3), 2018
PMID: 29797112
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V, Giron MC., Int J Mol Sci 19(6), 2018
PMID: 29882798
Functional variation in the gut microbiome of wild Drosophila populations.
Bost A, Martinson VG, Franzenburg S, Adair KL, Albasi A, Wells MT, Douglas AE., Mol Ecol 27(13), 2018
PMID: 29802796
The enteric nervous system in PD: gateway, bystander victim, or source of solutions.
Shannon K, Vanden Berghe P., Cell Tissue Res 373(1), 2018
PMID: 29936550
Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism.
Soto M, Herzog C, Pacheco JA, Fujisaka S, Bullock K, Clish CB, Kahn CR., Mol Psychiatry 23(12), 2018
PMID: 29910467
Potential Role of the Gut Microbiome in ALS: A Systematic Review.
Wright ML, Fournier C, Houser MC, Tansey M, Glass J, Hertzberg VS., Biol Res Nurs 20(5), 2018
PMID: 29925252
Protein Hydrolysates' Absorption Characteristics in the Dynamic Small Intestine In Vivo.
He Y, Shen L, Ma C, Chen M, Pan Y, Yin L, Zhou J, Lei X, Ren Q, Duan Y, Zhang H, Ma H., Molecules 23(7), 2018
PMID: 29966316
Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson's disease.
Chen QQ, Haikal C, Li W, Li MT, Wang ZY, Li JY., Transl Neurodegener 7(), 2018
PMID: 29988485
The gut-liver axis and the intersection with the microbiome.
Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R., Nat Rev Gastroenterol Hepatol 15(7), 2018
PMID: 29748586
Special issue "Parkinson's disease".
Braak H, Del Tredici-Braak K, Gasser T., Cell Tissue Res 373(1), 2018
PMID: 29882128
Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia.
Bouillon AS, Ventura Ferreira MS, Awad SA, Richter J, Hochhaus A, Kunzmann V, Dengler J, Janssen J, Ossenkoppele G, Westerweel PE, Te Boekhorst PAW, Mahon FX, Hjorth-Hansen H, Isfort S, Fioretos T, Hummel S, Schemionek M, Wilop S, Koschmieder S, Saußele S, Mustjoki S, Beier F, Brümmendorf TH., Blood Adv 2(13), 2018
PMID: 29980572
Gastrointestinal microbiota contributes to the development of murine transfusion-related acute lung injury.
Kapur R, Kim M, Rebetz J, Hallström B, Björkman JT, Takabe-French A, Kim N, Liu J, Shanmugabhavananthan S, Milosevic S, McVey MJ, Speck ER, Semple JW., Blood Adv 2(13), 2018
PMID: 29991496
Parkinson's disease: what the model systems have taught us so far.
Ghatak S, Trudler D, Dolatabadi N, Ambasudhan R., J Genet 97(3), 2018
PMID: 30027906
The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay?
Colonetti K, Roesch LF, Schwartz IVD., Genet Mol Biol 41(3), 2018
PMID: 30235399
Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialists.
Fackrell R, Carroll CB, Grosset DG, Mohamed B, Reddy P, Parry M, Chaudhuri KR, Foltynie T., Neurodegener Dis Manag 8(5), 2018
PMID: 29975112
Rethinking the Role of the Nervous System: Lessons From the Hydra Holobiont.
Klimovich AV, Bosch TCG., Bioessays 40(9), 2018
PMID: 29989180
Age-related changes in the gut microbiota influence systemic inflammation and stroke outcome.
Spychala MS, Venna VR, Jandzinski M, Doran SJ, Durgan DJ, Ganesh BP, Ajami NJ, Putluri N, Graf J, Bryan RM, McCullough LD., Ann Neurol 84(1), 2018
PMID: 29733457
Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice.
Torres ERS, Akinyeke T, Stagaman K, Duvoisin RM, Meshul CK, Sharpton TJ, Raber J., Front Behav Neurosci 12(), 2018
PMID: 30072879
The Gut Microbiota and Healthy Aging: A Mini-Review.
Kim S, Jazwinski SM., Gerontology 64(6), 2018
PMID: 30025401
Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism.
Zarrinpar A, Chaix A, Xu ZZ, Chang MW, Marotz CA, Saghatelian A, Knight R, Panda S., Nat Commun 9(1), 2018
PMID: 30030441
Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease.
Richards RI, Robertson SA, Kastner DL., Hum Mol Genet 27(r2), 2018
PMID: 29684205
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
Peter I, Dubinsky M, Bressman S, Park A, Lu C, Chen N, Wang A., JAMA Neurol 75(8), 2018
PMID: 29710331
Neurotransmitter modulation by the gut microbiota.
Strandwitz P., Brain Res 1693(pt b), 2018
PMID: 29903615
Tree Nut Consumption and Adipose Tissue Mass: Mechanisms of Action.
Tindall AM, Petersen KS, Lamendella R, Shearer GC, Murray-Kolb LE, Proctor DN, Kris-Etherton PM., Curr Dev Nutr 2(11), 2018
PMID: 30488045
Gut bacterial composition in a mouse model of Parkinson's disease.
Perez-Pardo P, Dodiya HB, Engen PA, Naqib A, Forsyth CB, Green SJ, Garssen J, Keshavarzian A, Kraneveld AD., Benef Microbes 9(5), 2018
PMID: 30099890
The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue.
Kirby TO, Ochoa-Repáraz J., Med Sci (Basel) 6(3), 2018
PMID: 30149548
Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M, Boehme M, Lyte JM, Wiley N, Strain C, O'Sullivan O, Clarke G, Stanton C, Dinan TG, Cryan JF., J Physiol 596(20), 2018
PMID: 30066368
The Microbiome Regulates Pulmonary Responses to Ozone in Mice.
Cho Y, Abu-Ali G, Tashiro H, Kasahara DI, Brown TA, Brand JD, Mathews JA, Huttenhower C, Shore SA., Am J Respir Cell Mol Biol 59(3), 2018
PMID: 29529379
Neuroimmune mechanisms of psychostimulant and opioid use disorders.
Hofford RS, Russo SJ, Kiraly DD., Eur J Neurosci (), 2018
PMID: 30179286
The role of gut microbiota in lupus: what we know in 2018?
Ruiz L, López P, Suárez A, Sánchez B, Margolles A., Expert Rev Clin Immunol 14(10), 2018
PMID: 30173572
The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence.
Lee K, Vuong HE, Nusbaum DJ, Hsiao EY, Evans CJ, Taylor AMW., Neuropsychopharmacology 43(13), 2018
PMID: 30258112
Emerging Role of Diet and Microbiota Interactions in Neuroinflammation.
Janakiraman M, Krishnamoorthy G., Front Immunol 9(), 2018
PMID: 30254641
Gut-Brain Psychology: Rethinking Psychology From the Microbiota-Gut-Brain Axis.
Liang S, Wu X, Jin F., Front Integr Neurosci 12(), 2018
PMID: 30271330
Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women.
Palacios N, Hughes KC, Cereda E, Schwarzschild MA, Ascherio A., Mov Disord 33(9), 2018
PMID: 30218460
The intestinal microbiome and Alzheimer's disease: A review.
Li Z, Zhu H, Zhang L, Qin C., Animal Model Exp Med 1(3), 2018
PMID: 30891563
Converging pathways in neurodegeneration, from genetics to mechanisms.
Gan L, Cookson MR, Petrucelli L, La Spada AR., Nat Neurosci 21(10), 2018
PMID: 30258237
The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?
Jiang T, Li G, Xu J, Gao S, Chen X., Front Immunol 9(), 2018
PMID: 30319601
A Metabolomic-Based Evaluation of the Role of Commensal Microbiota throughout the Gastrointestinal Tract in Mice.
Yamamoto Y, Nakanishi Y, Murakami S, Aw W, Tsukimi T, Nozu R, Ueno M, Hioki K, Nakahigashi K, Hirayama A, Sugimoto M, Soga T, Ito M, Tomita M, Fukuda S., Microorganisms 6(4), 2018
PMID: 30274293
Microglial signatures and their role in health and disease.
Butovsky O, Weiner HL., Nat Rev Neurosci 19(10), 2018
PMID: 30206328
Taming the beasts within.
Martinez J., Nat Microbiol 3(10), 2018
PMID: 30254330
Impact of vegan diets on gut microbiota: An update on the clinical implications.
Wong MW, Yi CH, Liu TT, Lei WY, Hung JS, Lin CL, Lin SZ, Chen CL., Ci Ji Yi Xue Za Zhi 30(4), 2018
PMID: 30305781
Defining Dysbiosis in Disorders of Movement and Motivation.
Fields CT, Sampson TR, Bruce-Keller AJ, Kiraly DD, Hsiao EY, de Vries GJ., J Neurosci 38(44), 2018
PMID: 30381433
Peripheral immune system in aging and Alzheimer's disease.
Cao W, Zheng H., Mol Neurodegener 13(1), 2018
PMID: 30285785
Oleoylethanolamide treatment affects gut microbiota composition and the expression of intestinal cytokines in Peyer's patches of mice.
Di Paola M, Bonechi E, Provensi G, Costa A, Clarke G, Ballerini C, De Filippo C, Passani MB., Sci Rep 8(1), 2018
PMID: 30291258
The Gut-Microglia Connection: Implications for Central Nervous System Diseases.
Wang Y, Wang Z, Wang Y, Li F, Jia J, Song X, Qin S, Wang R, Jin F, Kitazato K, Wang Y., Front Immunol 9(), 2018
PMID: 30344525
Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease.
Troncoso-Escudero P, Parra A, Nassif M, Vidal RL., Front Neurol 9(), 2018
PMID: 30459700
Cannabis Therapeutics and the Future of Neurology.
Russo EB., Front Integr Neurosci 12(), 2018
PMID: 30405366
Gastrointestinal Dysfunction in Parkinson's Disease.
Pfeiffer RF., Curr Treat Options Neurol 20(12), 2018
PMID: 30361783
Antibiotic and Modulation of Microbiota: A New Paradigm?
Rizzatti G, Ianiro G, Gasbarrini A., J Clin Gastroenterol 52 Suppl 1, Proceedings from the 9th Probiotics, Prebio(), 2018
PMID: 29912755
Central Nervous System Responses to Simulated Galactic Cosmic Rays.
Cekanaviciute E, Rosi S, Costes SV., Int J Mol Sci 19(11), 2018
PMID: 30463349
Commensal Bacteria-Specific CD4+ T Cell Responses in Health and Disease.
Sorini C, Cardoso RF, Gagliani N, Villablanca EJ., Front Immunol 9(), 2018
PMID: 30524431
Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium.
Sharkey KA, Beck PL, McKay DM., Nat Rev Gastroenterol Hepatol 15(12), 2018
PMID: 30069036
Polyphenols-gut microbiota interplay and brain neuromodulation.
Filosa S, Di Meo F, Crispi S., Neural Regen Res 13(12), 2018
PMID: 30323120
Oxidative Stress and the Microbiota-Gut-Brain Axis.
Dumitrescu L, Popescu-Olaru I, Cozma L, Tulbă D, Hinescu ME, Ceafalan LC, Gherghiceanu M, Popescu BO., Oxid Med Cell Longev 2018(), 2018
PMID: 30622664
Advances in Parkinson's Disease: 200 Years Later.
Del Rey NL, Quiroga-Varela A, Garbayo E, Carballo-Carbajal I, Fernández-Santiago R, Monje MHG, Trigo-Damas I, Blanco-Prieto MJ, Blesa J., Front Neuroanat 12(), 2018
PMID: 30618654
A Metabologenomic Approach Reveals Changes in the Intestinal Environment of Mice Fed on American Diet.
Ishii C, Nakanishi Y, Murakami S, Nozu R, Ueno M, Hioki K, Aw W, Hirayama A, Soga T, Ito M, Tomita M, Fukuda S., Int J Mol Sci 19(12), 2018
PMID: 30562947
Extracellular Interactions of Alpha-Synuclein in Multiple System Atrophy.
Valdinocci D, Radford RAW, Goulding M, Hayashi J, Chung RS, Pountney DL., Int J Mol Sci 19(12), 2018
PMID: 30572656
Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease.
Suzuki A, Ito M, Hamaguchi T, Mori H, Takeda Y, Baba R, Watanabe T, Kurokawa K, Asakawa S, Hirayama M, Ohno K., PLoS One 13(12), 2018
PMID: 30586410
Top Altmetric Scores in the Parkinson's Disease Literature.
Araújo R, Sorensen AA, Konkiel S, Bloem BR., J Parkinsons Dis 7(1), 2017
PMID: 28222540
The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy.
Engen PA, Dodiya HB, Naqib A, Forsyth CB, Green SJ, Voigt RM, Kordower JH, Mutlu EA, Shannon KM, Keshavarzian A., J Parkinsons Dis 7(2), 2017
PMID: 28234259
The Gut Microbiota and Alzheimer's Disease.
Jiang C, Li G, Huang P, Liu Z, Zhao B., J Alzheimers Dis 58(1), 2017
PMID: 28372330
Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease.
Zhang L, Wang Y, Xiayu X, Shi C, Chen W, Song N, Fu X, Zhou R, Xu YF, Huang L, Zhu H, Han Y, Qin C., J Alzheimers Dis 60(4), 2017
PMID: 29036812
Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease?
Thirtamara-Rajamani K, Li P, Escobar Galvis ML, Labrie V, Brundin P, Brundin L., J Parkinsons Dis 7(4), 2017
PMID: 29103054
Gut microbiota in 2016: A banner year for gut microbiota research.
Garrett WS., Nat Rev Gastroenterol Hepatol 14(2), 2017
PMID: 28074073
Gut microbiota: A player in aging and a target for anti-aging intervention.
Vaiserman AM, Koliada AK, Marotta F., Ageing Res Rev 35(), 2017
PMID: 28109835
Parkinson's disease: Oh my gut!
Del Rey NL, Blesa J., Mov Disord 32(3), 2017
PMID: 28151555
Gut microbiota: Implications in Parkinson's disease.
Parashar A, Udayabanu M., Parkinsonism Relat Disord 38(), 2017
PMID: 28202372
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H., Mov Disord 32(5), 2017
PMID: 28195358
The chicken or the egg dilemma: intestinal dysbiosis in multiple sclerosis.
Ochoa-Repáraz J, Magori K, Kasper LH., Ann Transl Med 5(6), 2017
PMID: 28462225
Gut Feelings on Parkinson's and Depression.
Dinan TG, Cryan JF., Cerebrum 2017(), 2017
PMID: 28698775
Dysbiosis and the immune system.
Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E., Nat Rev Immunol 17(4), 2017
PMID: 28260787
Recent advances in treating Parkinson's disease.
Oertel WH., F1000Res 6(), 2017
PMID: 28357055
The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.
Thomas S, Izard J, Walsh E, Batich K, Chongsathidkiet P, Clarke G, Sela DA, Muller AJ, Mullin JM, Albert K, Gilligan JP, DiGuilio K, Dilbarova R, Alexander W, Prendergast GC., Cancer Res 77(8), 2017
PMID: 28292977
The gut microbiome in human neurological disease: A review.
Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E., Ann Neurol 81(3), 2017
PMID: 28220542
The Microbiome and Human Biology.
Knight R, Callewaert C, Marotz C, Hyde ER, Debelius JW, McDonald D, Sogin ML., Annu Rev Genomics Hum Genet 18(), 2017
PMID: 28375652
Parkinson disease.
Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE., Nat Rev Dis Primers 3(), 2017
PMID: 28332488
Microbial Immuno-Communication in Neurodegenerative Diseases.
Main BS, Minter MR., Front Neurosci 11(), 2017
PMID: 28386215
Gut-Brain Axis and Behavior.
Martin CR, Mayer EA., Nestle Nutr Inst Workshop Ser 88(), 2017
PMID: 28346923
Nature Biotechnology's academic spinouts of 2016.
Bouchie A, DeFrancesco L, Sheridan C, Webb S., Nat Biotechnol 35(4), 2017
PMID: 28398323
Media hype: Patient and scientific perspectives on misleading medical news.
Robledo I, Jankovic J., Mov Disord 32(9), 2017
PMID: 28370445
Microbiology: Gut microbes augment neurodegeneration.
Erny D, Prinz M., Nature 544(7650), 2017
PMID: 28405021
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, Wüllner U., Genome Med 9(1), 2017
PMID: 28449715
C14orf28 downregulated by miR-519d contributes to oncogenicity and regulates apoptosis and EMT in colorectal cancer.
Yang X, Hu Y, Liu Y, Liu W, Zhao X, Liu M, Tang H., Mol Cell Biochem 434(1-2), 2017
PMID: 28455792
A neurorestorative approach to Parkinson's disease.
Diana G, Ciotti MT, Musilli M., Oncotarget 8(21), 2017
PMID: 28423348
Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects.
Tomlinson JJ, Shutinoski B, Dong L, Meng F, Elleithy D, Lengacher NA, Nguyen AP, Cron GO, Jiang Q, Roberson ED, Nussbaum RL, Majbour NK, El-Agnaf OM, Bennett SA, Lagace DC, Woulfe JM, Sad S, Brown EG, Schlossmacher MG., J Neural Transm (Vienna) 124(6), 2017
PMID: 28477284
Metal Transporter Zip14 (Slc39a14) Deletion in Mice Increases Manganese Deposition and Produces Neurotoxic Signatures and Diminished Motor Activity.
Aydemir TB, Kim MH, Kim J, Colon-Perez LM, Banan G, Mareci TH, Febo M, Cousins RJ., J Neurosci 37(25), 2017
PMID: 28536273
Molecular Imaging in Synthetic Biology, and Synthetic Biology in Molecular Imaging.
Gilad AA, Shapiro MG., Mol Imaging Biol 19(3), 2017
PMID: 28213833
Sleep Disturbances in the Prodromal Stage of Parkinson Disease.
Al-Qassabi A, Fereshtehnejad SM, Postuma RB., Curr Treat Options Neurol 19(6), 2017
PMID: 28466429
α-Synuclein in gut endocrine cells and its implications for Parkinson's disease.
Chandra R, Hiniker A, Kuo YM, Nussbaum RL, Liddle RA., JCI Insight 2(12), 2017
PMID: 28614796
Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.
Delic V, Griffin JWD, Zivkovic S, Zhang Y, Phan TA, Gong H, Chaput D, Reynes C, Dinh VB, Cruz J, Cvitkovic E, Placides D, Frederic E, Mirzaei H, Stevens SM, Jinwal U, Lee DC, Bradshaw PC., Neuromolecular Med 19(2-3), 2017
PMID: 28620826
Toward a genetic tool development pipeline for host-associated bacteria.
Waller MC, Bober JR, Nair NU, Beisel CL., Curr Opin Microbiol 38(), 2017
PMID: 28624690
16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain.
Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, Davies M, West NX, Allen SJ., Front Aging Neurosci 9(), 2017
PMID: 28676754
Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit.
Tohidpour A, Morgun AV, Boitsova EB, Malinovskaya NA, Martynova GP, Khilazheva ED, Kopylevich NV, Gertsog GE, Salmina AB., Front Cell Infect Microbiol 7(), 2017
PMID: 28676848
Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.
Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S., Cell Mol Life Sci 74(20), 2017
PMID: 28643167
A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity.
Stolzenberg E, Berry D, Yang, Lee EY, Kroemer A, Kaufman S, Wong GCL, Oppenheim JJ, Sen S, Fishbein T, Bax A, Harris B, Barbut D, Zasloff MA., J Innate Immun 9(5), 2017
PMID: 28651250
The remedy within: will the microbiome fulfill its therapeutic promise?
Thaiss CA, Elinav E., J Mol Med (Berl) 95(10), 2017
PMID: 28656322
The microbiome: current and future view of an ancient paradigm.
Neish AS, Pacifici R, Mulle JG, Kraft CS, Stephens DS., Future Microbiol 12(), 2017
PMID: 28660775
Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation.
Wlodarska M, Luo C, Kolde R, d'Hennezel E, Annand JW, Heim CE, Krastel P, Schmitt EK, Omar AS, Creasey EA, Garner AL, Mohammadi S, O'Connell DJ, Abubucker S, Arthur TD, Franzosa EA, Huttenhower C, Murphy LO, Haiser HJ, Vlamakis H, Porter JA, Xavier RJ., Cell Host Microbe 22(1), 2017
PMID: 28704649
Regulation of inflammation by microbiota interactions with the host.
Blander JM, Longman RS, Iliev ID, Sonnenberg GF, Artis D., Nat Immunol 18(8), 2017
PMID: 28722709
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.
Namasivayam S, Maiga M, Yuan W, Thovarai V, Costa DL, Mittereder LR, Wipperman MF, Glickman MS, Dzutsev A, Trinchieri G, Sher A., Microbiome 5(1), 2017
PMID: 28683818
Teleosts as Model Organisms To Understand Host-Microbe Interactions.
Lescak EA, Milligan-Myhre KC., J Bacteriol 199(15), 2017
PMID: 28439034
Progress toward an integrated understanding of Parkinson's disease.
Rousseaux MWC, Shulman JM, Jankovic J., F1000Res 6(), 2017
PMID: 28751973
An unexplored brain-gut microbiota axis in stroke.
Wen SW, Wong CHY., Gut Microbes 8(6), 2017
PMID: 28640714
The human microbiome.
Blum HE., Adv Med Sci 62(2), 2017
PMID: 28711782
Perspective: Neuroregenerative Nutrition.
Steindler DA, Reynolds BA., Adv Nutr 8(4), 2017
PMID: 28710142
Eating Disorders and the Intestinal Microbiota: Mechanisms of Energy Homeostasis and Behavioral Influence.
Glenny EM, Bulik-Sullivan EC, Tang Q, Bulik CM, Carroll IM., Curr Psychiatry Rep 19(8), 2017
PMID: 28676966
Influence of gut microbiota on neuropsychiatric disorders.
Cenit MC, Sanz Y, Codoñer-Franch P., World J Gastroenterol 23(30), 2017
PMID: 28852308
Biomarker Research in Parkinson's Disease Using Metabolite Profiling.
Havelund JF, Heegaard NHH, Færgeman NJK, Gramsbergen JB., Metabolites 7(3), 2017
PMID: 28800113
Non-CNS pathogenic origin of Parkinson's disease.
Choudhry H, Perlmuter LC., J Neurol 264(9), 2017
PMID: 28808780
Regulation of life span by the gut microbiota in the short-lived African turquoise killifish.
Smith P, Willemsen D, Popkes M, Metge F, Gandiwa E, Reichard M, Valenzano DR., Elife 6(), 2017
PMID: 28826469
Timing the Microbes: The Circadian Rhythm of the Gut Microbiome.
Liang X, FitzGerald GA., J Biol Rhythms 32(6), 2017
PMID: 28862076
Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1ΔE9 murine model of Alzheimer's disease.
Minter MR, Hinterleitner R, Meisel M, Zhang C, Leone V, Zhang X, Oyler-Castrillo P, Zhang X, Musch MW, Shen X, Jabri B, Chang EB, Tanzi RE, Sisodia SS., Sci Rep 7(1), 2017
PMID: 28874832
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models.
Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL, Crabtree-Hartman E, Sand IK, Gacias M, Zhu Y, Casaccia P, Cree BAC, Knight R, Mazmanian SK, Baranzini SE., Proc Natl Acad Sci U S A 114(40), 2017
PMID: 28893978
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.
Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, Liu C, Klotz L, Stauffer U, Baranzini SE, Kümpfel T, Hohlfeld R, Krishnamoorthy G, Wekerle H., Proc Natl Acad Sci U S A 114(40), 2017
PMID: 28893994
How can computation advance microbiome research?
Nussinov R, Papin JA., PLoS Comput Biol 13(9), 2017
PMID: 28934204
A gut feeling about multiple sclerosis.
Quintana FJ, Prinz M., Proc Natl Acad Sci U S A 114(40), 2017
PMID: 28973867
CD4+ T cells from multiple sclerosis patients respond to a commensal-derived antigen.
Burgess JN, Pant AB, Kasper LH, Colpitts Brass S., Ann Clin Transl Neurol 4(11), 2017
PMID: 29159195
Implications of peptide assemblies in amyloid diseases.
Ke PC, Sani MA, Ding F, Kakinen A, Javed I, Separovic F, Davis TP, Mezzenga R., Chem Soc Rev 46(21), 2017
PMID: 28702523
Prying into the Prion Hypothesis for Parkinson's Disease.
Brundin P, Melki R., J Neurosci 37(41), 2017
PMID: 29021298
Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something.
Kodukula K, Faller DV, Harpp DN, Kanara I, Pernokas J, Pernokas M, Powers WR, Soukos NS, Steliou K, Moos WH., Biores Open Access 6(1), 2017
PMID: 29098118
The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition.
Eskandari-Sedighi G, Daude N, Gapeshina H, Sanders DW, Kamali-Jamil R, Yang J, Shi B, Wille H, Ghetti B, Diamond MI, Janus C, Westaway D., Mol Neurodegener 12(1), 2017
PMID: 28978354
Amino acid supplements and metabolic health: a potential interplay between intestinal microbiota and systems control.
Bifari F, Ruocco C, Decimo I, Fumagalli G, Valerio A, Nisoli E., Genes Nutr 12(), 2017
PMID: 29043007
The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists.
Lerner A, Neidhöfer S, Matthias T., Microorganisms 5(4), 2017
PMID: 29023380
Structural host-microbiota interaction networks.
Guven-Maiorov E, Tsai CJ, Nussinov R., PLoS Comput Biol 13(10), 2017
PMID: 29023448
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.
Quigley EMM., Curr Neurol Neurosci Rep 17(12), 2017
PMID: 29039142
Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study.
Minato T, Maeda T, Fujisawa Y, Tsuji H, Nomoto K, Ohno K, Hirayama M., PLoS One 12(11), 2017
PMID: 29091972
[When germs get involved in Parkinson's disease].
Khenniche Y, Lutete E, Bobé P., Med Sci (Paris) 33(11), 2017
PMID: 29200392
Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson's Disease.
Perez-Pardo P, Hartog M, Garssen J, Kraneveld AD., Curr Behav Neurosci Rep 4(4), 2017
PMID: 29201595
Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides.
Xiong M, Bao Y, Xu X, Wang H, Han Z, Wang Z, Liu Y, Huang S, Song Z, Chen J, Peek RM, Yin L, Chen LF, Cheng J., Proc Natl Acad Sci U S A 114(48), 2017
PMID: 29133389
A transatlantic perspective on 20 emerging issues in biological engineering.
Wintle BC, Boehm CR, Rhodes C, Molloy JC, Millett P, Adam L, Breitling R, Carlson R, Casagrande R, Dando M, Doubleday R, Drexler E, Edwards B, Ellis T, Evans NG, Hammond R, Haseloff J, Kahl L, Kuiken T, Lichman BR, Matthewman CA, Napier JA, ÓhÉigeartaigh SS, Patron NJ, Perello E, Shapira P, Tait J, Takano E, Sutherland WJ., Elife 6(), 2017
PMID: 29132504
Probiotic, Prebiotic, and Brain Development.
Cerdó T, Ruíz A, Suárez A, Campoy C., Nutrients 9(11), 2017
PMID: 29135961
Visceral Inflammation and Immune Activation Stress the Brain.
Holzer P, Farzi A, Hassan AM, Zenz G, Jačan A, Reichmann F., Front Immunol 8(), 2017
PMID: 29213271
Vertebrate food products as a potential source of prion-like α-synuclein.
Killinger BA, Labrie V., NPJ Parkinsons Dis 3(), 2017
PMID: 29184902
Microbiota and neurodegenerative diseases.
Marizzoni M, Provasi S, Cattaneo A, Frisoni GB., Curr Opin Neurol 30(6), 2017
PMID: 28906270
Biological and Clinical Implications of Comorbidities in Parkinson's Disease.
Santiago JA, Bottero V, Potashkin JA., Front Aging Neurosci 9(), 2017
PMID: 29255414
The role of microbial amyloid in neurodegeneration.
Friedland RP, Chapman MR., PLoS Pathog 13(12), 2017
PMID: 29267402

74 References

Daten bereitgestellt von Europe PubMed Central.

Genes associated with Parkinson's disease: regulation of autophagy and beyond
Beilina A, Cookson MR., 2015
The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice.
Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, Verdu EF, Collins SM., Gastroenterology 141(2), 2011
PMID: 21683077
The gut microbiota influences blood-brain barrier permeability in mice.
Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, Korecka A, Bakocevic N, Ng LG, Guan NL, Kundu P, Gulyas B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B, Pettersson S., Sci Transl Med 6(263), 2014
PMID: 25411471
Spreading of pathology in neurodegenerative diseases: a focus on human studies.
Brettschneider J, Del Tredici K, Lee VM, Trojanowski JQ., Nat. Rev. Neurosci. 16(2), 2015
PMID: 25588378
A critical evaluation of the Braak staging scheme for Parkinson's disease.
Burke RE, Dauer WT, Vonsattel JP., Ann. Neurol. 64(5), 2008
PMID: 19067353
QIIME allows analysis of high-throughput community sequencing data.
Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R., Nat. Methods 7(5), 2010
PMID: 20383131
A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice.
Chesselet MF, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR., Neurotherapeutics 9(2), 2012
PMID: 22350713
Bacterial Chaperones CsgE and CsgC Differentially Modulate Human α-Synuclein Amyloid Formation via Transient Contacts.
Chorell E, Andersson E, Evans ML, Jain N, Gotheson A, Aden J, Chapman MR, Almqvist F, Wittung-Stafshede P., PLoS ONE 10(10), 2015
PMID: 26465894
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner.
Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF., Mol. Psychiatry 18(6), 2012
PMID: 22688187
Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease.
Cleynen I, Vazeille E, Artieda M, Verspaget HW, Szczypiorska M, Bringer MA, Lakatos PL, Seibold F, Parnell K, Weersma RK, Mahachie John JM, Morgan-Walsh R, Staelens D, Arijs I, De Hertogh G, Muller S, Tordai A, Hommes DW, Ahmad T, Wijmenga C, Pender S, Rutgeerts P, Van Steen K, Lottaz D, Vermeire S, Darfeuille-Michaud A., Gut 63(8), 2013
PMID: 24092863
A not entirely benign procedure: progression of Parkinson's disease.
Del Tredici K, Braak H., Acta Neuropathol. 115(4), 2008
PMID: 18320198
Colonic inflammation in Parkinson's disease.
Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, Coron E, Bruley des Varannes S, Naveilhan P, Nguyen JM, Neunlist M, Derkinderen P., Neurobiol. Dis. 50(), 2012
PMID: 23017648
Normal gut microbiota modulates brain development and behavior.
Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S., Proc. Natl. Acad. Sci. U.S.A. 108(7), 2011
PMID: 21282636
The impact of gut microbiota on brain and behaviour: implications for psychiatry.
Dinan TG, Cryan JF., Curr Opin Clin Nutr Metab Care 18(6), 2015
PMID: 26372511
Substantial production of dopamine in the human gastrointestinal tract.
Eisenhofer G, Aneman A, Friberg P, Hooper D, Fandriks L, Lonroth H, Hunyady B, Mezey E., J. Clin. Endocrinol. Metab. 82(11), 1997
PMID: 9360553
Host microbiota constantly control maturation and function of microglia in the CNS.
Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Utermohlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M., Nat. Neurosci. 18(7), 2015
PMID: 26030851
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.
Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF., J. Neurosci. 24(42), 2004
PMID: 15496679
Gender-Specific Effects of Organophosphate Diazinon on the Gut Microbiome and Its Metabolic Functions
Gao B, Bian X, Mahbub R, Lu K., 2016
The Earth Microbiome project: successes and aspirations.
Gilbert JA, Jansson JK, Knight R., BMC Biol. 12(), 2014
PMID: 25184604
Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease.
Hasegawa S, Goto S, Tsuji H, Okuno T, Asahara T, Nomoto K, Shibata A, Fujisawa Y, Minato T, Okamoto A, Ohno K, Hirayama M., PLoS ONE 10(11), 2015
PMID: 26539989
Regulation of prefrontal cortex myelination by the microbiota.
Hoban AE, Stilling RM, Ryan FJ, Shanahan F, Dinan TG, Claesson MJ, Clarke G, Cryan JF., Transl Psychiatry 6(), 2016
PMID: 27045844
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats.
Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, Li JY., Acta Neuropathol. 128(6), 2014
PMID: 25296989
Interactions between the microbiota and the immune system.
Hooper LV, Littman DR, Macpherson AJ., Science 336(6086), 2012
PMID: 22674334
Molecular mechanisms of L-DOPA-induced dyskinesia.
Jenner P., Nat. Rev. Neurosci. 9(9), 2008
PMID: 18714325
alpha-Synuclein membrane interactions and lipid specificity.
Jo E, McLaurin J, Yip CM, St George-Hyslop P, Fraser PE., J. Biol. Chem. 275(44), 2000
PMID: 10915790
The role of innate and adaptive immunity in Parkinson's disease.
Kannarkat GT, Boss JM, Tansey MG., J Parkinsons Dis 3(4), 2013
PMID: 24275605
Colonic bacterial composition in Parkinson's disease.
Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM., Mov. Disord. 30(10), 2015
PMID: 26179554
Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.
Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, Joong Lee S, Masliah E, Hwang D, Lee HJ, Lee SJ., Nat Commun 4(), 2013
PMID: 23463005
Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte ET, Frosch M, Growdon J, McLean P, Hyman BT., Acta Neuropathol. 111(2), 2006
PMID: 16482476
Effects of minocycline on spatial learning, hippocampal neurogenesis and microglia in aged and adult mice.
Kohman RA, Bhattacharya TK, Kilby C, Bucko P, Rhodes JS., Behav. Brain Res. 242(), 2012
PMID: 23274840
SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data.
Kopylova E, Noe L, Touzet H., Bioinformatics 28(24), 2012
PMID: 23071270
Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease
Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, Lefkowitz A, McColl G, Goldstein LE, Tanzi RE., 2016
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences.
Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, Beiko RG, Huttenhower C., Nat. Biotechnol. 31(9), 2013
PMID: 23975157
Four types of Bifidobacteria trigger autophagy response in intestinal epithelial cells.
Lin R, Jiang Y, Zhao XY, Guan Y, Qian W, Fu XC, Ren HY, Hou XH., J Dig Dis 15(11), 2014
PMID: 25123057
UniFrac: a new phylogenetic method for comparing microbial communities.
Lozupone C, Knight R., Appl. Environ. Microbiol. 71(12), 2005
PMID: 16332807
Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.
Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VM., Science 338(6109), 2012
PMID: 23161999
Analysis of composition of microbiomes: a novel method for studying microbial composition.
Mandal S, Van Treuren W, White RA, Eggesbo M, Knight R, Peddada SD., Microb. Ecol. Health Dis. 26(), 2015
PMID: 26028277
Microglia development follows a stepwise program to regulate brain homeostasis.
Matcovitch-Natan O, Winter DR, Giladi A, Vargas Aguilar S, Spinrad A, Sarrazin S, Ben-Yehuda H, David E, Zelada Gonzalez F, Perrin P, Keren-Shaul H, Gury M, Lara-Astaiso D, Thaiss CA, Cohen M, Bahar Halpern K, Baruch K, Deczkowska A, Lorenzo-Vivas E, Itzkovitz S, Elinav E, Sieweke MH, Schwartz M, Amit I., Science 353(6301), 2016
PMID: 27338705
Altered brain-gut axis in autism: comorbidity or causative mechanisms?
Mayer EA, Padua D, Tillisch K., Bioessays 36(10), 2014
PMID: 25145752
An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea.
McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, Andersen GL, Knight R, Hugenholtz P., ISME J 6(3), 2011
PMID: 22134646
Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease.
Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, Musch MW, Liao F, Ward JF, Holtzman DM, Chang EB, Tanzi RE, Sisodia SS., Sci Rep 6(), 2016
PMID: 27443609
Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients.
Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T., Neurosci. Lett. 180(2), 1994
PMID: 7700568
Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.
Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T., Neurosci. Lett. 165(1-2), 1994
PMID: 8015728
Ly6Chi Monocytes Provide a Link between Antibiotic-Induced Change in Gut Microbiota and Adult Hippocampal Neurogenesis
Mohle L, Mattei D, Heimesaat MM, Bereswill S, Fischer A, Alutis M, French T, Hambardzumyan D, Matzinger P, Dunay IR., 2016
Reduced anxiety-like behavior and central neurochemical change in germ-free mice.
Neufeld KM, Kang N, Bienenstock J, Foster JA., Neurogastroenterol. Motil. 23(3), 2010
PMID: 21054680
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.
Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, Patel S, Oehler A, Lowe JK, Kravitz SN, Geschwind DH, Glidden DV, Halliday GM, Middleton LT, Gentleman SM, Grinberg LT, Giles K., Proc. Natl. Acad. Sci. U.S.A. 112(38), 2015
PMID: 26324905
Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease.
Ritz BR, Paul KC, Bronstein JM., Curr Environ Health Rep 3(1), 2016
PMID: 26857251
Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.
Rockenstein E, Mallory M, Hashimoto M, Song D, Shults CW, Lang I, Masliah E., J. Neurosci. Res. 68(5), 2002
PMID: 12111846
Gut microbiota, metabolites and host immunity.
Rooks MG, Garrett WS., Nat. Rev. Immunol. 16(6), 2016
PMID: 27231050
Therapeutic strategies for human amyloid diseases.
Sacchettini JC, Kelly JW., Nat Rev Drug Discov 1(4), 2002
PMID: 12120278
Gut microbiota are related to Parkinson's disease and clinical phenotype.
Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P., Mov. Disord. 30(3), 2014
PMID: 25476529
Signals from the gut microbiota to distant organs in physiology and disease.
Schroeder BO, Backhed F., Nat. Med. 22(10), 2016
PMID: 27711063
Metabolic tinkering by the gut microbiome: Implications for brain development and function.
Selkrig J, Wong P, Zhang X, Pettersson S., Gut Microbes 5(3), 2014
PMID: 24685620
Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH., Mov. Disord. 27(6), 2012
PMID: 22550057
The Central Nervous System and the Gut Microbiome.
Sharon G, Sampson TR, Geschwind DH, Mazmanian SK., Cell 167(4), 2016
PMID: 27814521
The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.
Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS., Science 341(6145), 2013
PMID: 23828891
Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.
Soldner F, Stelzer Y, Shivalila CS, Abraham BJ, Latourelle JC, Barrasa MI, Goldmann J, Myers RH, Young RA, Jaenisch R., Nature 533(7601), 2016
PMID: 27096366
Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice.
Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y., J. Physiol. (Lond.) 558(Pt 1), 2004
PMID: 15133062
Vagotomy and subsequent risk of Parkinson's disease.
Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, Sorensen HT., Ann. Neurol. 78(4), 2015
PMID: 26031848
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Burmann J, Fassbender K, Schwiertz A, Schafer KH., 2016
EMPeror: a tool for visualizing high-throughput microbial community data.
Vazquez-Baeza Y, Pirrung M, Gonzalez A, Knight R., Gigascience 2(1), 2013
PMID: 24280061
Patient-reported autonomic symptoms in Parkinson disease.
Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ., Neurology 69(4), 2007
PMID: 17646625
Bacterial neuroactive compounds produced by psychobiotics.
Wall R, Cryan JF, Ross RP, Fitzgerald GF, Dinan TG, Stanton C., Adv. Exp. Med. Biol. 817(), 2014
PMID: 24997036
Improved Bacterial 16S rRNA Gene (V4 and V4-5) and Fungal Internal Transcribed Spacer Marker Gene Primers for Microbial Community Surveys
Walters W, Hyde ER, Berg-Lyons D, Ackermann G, Humphrey G, Parada A, Gilbert JA, Jansson JK, Caporaso JG, Fuhrman JA., 2016
Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.
Wang L, Magen I, Yuan PQ, Subramaniam SR, Richter F, Chesselet MF, Tache Y., Neurogastroenterol. Motil. 24(9), 2012
PMID: 22779732
Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis.
Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY., Cell 161(2), 2015
PMID: 25860609
Motor impairments, striatal degeneration, and altered dopamine-glutamate interplay in mice lacking PSD-95.
Zhang J, Saur T, Duke AN, Grant SG, Platt DM, Rowlett JK, Isacson O, Yao WD., J. Neurogenet. 28(1-2), 2014
PMID: 24702501

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 27912057
PubMed | Europe PMC

Suchen in

Google Scholar
ISBN Suche